Kuwait MOH Clinical Psychologist cheat sheet

DSM-5-TR requires symptoms cause clinically significant distress or impairment; a syndrome without impairment does not meet threshold for most disorders.

Major depressive episode: ≥5 of 9 symptoms for ≥2 weeks, including depressed mood or anhedonia; exclude mania/hypomania before coding.

Schizophrenia requires ≥2 Criterion A symptoms (delusions, hallucinations, disorganized speech, grossly disorganized/catatonic behavior, negative symptoms) with ≥1 from first three, ≥6 months duration.

Bipolar I needs ≥1 manic episode (≥1 week or hospitalization); bipolar II needs hypomania (≥4 days) plus major depression, never mania.

Panic disorder = recurrent unexpected panic attacks plus ≥1 month of anticipatory anxiety or maladaptive behavior change.

GAD: excessive worry ≥6 months, ≥3 of 6 symptoms in adults (1 of 3 in children), plus distress/impairment.

PTSD: trauma exposure plus ≥1 intrusion, ≥1 avoidance, ≥2 negative cognition/mood, ≥2 arousal/reactivity symptoms, >1 month, causing impairment.

OCD is coded separately from anxiety disorders in DSM-5; insight specifiers (good/fair, poor, absent/delusional) and tic-related specifier apply.

Differential rule: medical/ substance etiology takes precedence; code substance-induced or due to another medical condition before primary psychiatric disorder.

Reliability = consistency; internal consistency via Cronbach's alpha (≥0.70 acceptable for research, ≥0.90 for clinical decisions).

Standard error of measurement: SEM = SD × √(1 − reliability); 95% CI ≈ observed score ± 1.96 × SEM.

Validity types: face, content, criterion (concurrent/predictive), construct (convergent/discriminant).

IQ scores: mean 100, SD 15; index scores likewise; 68% within ±1 SD, 95% within ±2 SD.

WAIS-IV/WISC-V index structure: Verbal Comprehension, Perceptual Reasoning/Visual Spatial, Working Memory/Fluid Reasoning, Processing Speed.

MMPI-2 validity scales: L (naive virtue), F (infrequency/overreporting), K (defensiveness); F-r and Fp improve detection of feigning.

Sensitivity = true positives/(true positives + false negatives); specificity = true negatives/(true negatives + false positives); predictive value depends on base rate.

Neuropsychological screening: MoCA cutoff <26 suggests cognitive impairment; adjust for education; MMSE less sensitive to mild impairment.

Test selection: match instrument to referral question, language, reading level, and cultural norms; use validated Arabic versions where available.

CBT core: cognitive model links situation → automatic thought → emotion/behavior; interventions include cognitive restructuring, behavioral experiments, exposure, activity scheduling.

Behavioral activation targets avoidance and reinforcement loss in depression; schedule mastery and pleasure activities graded by difficulty.

Exposure therapy: graded hierarchy, prolonged exposure to feared stimulus without escape, response prevention for OCD; habituation is the mechanism.

DBT four modules: mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness; targets dialectic of acceptance and change.

Psychodynamic concepts: transference, countertransference, defense mechanisms, working alliance; interpret resistance rather than confront.

Motivational interviewing: OARS (open questions, affirmations, reflections, summaries); rolling with resistance, developing discrepancy, supporting self-efficacy.

Systematic desensitization pairs relaxation with anxiety hierarchy; in vivo exposure generally outperforms imaginal for phobias.

Group therapy therapeutic factors (Yalom): universality, instillation of hope, altruism, interpersonal learning, catharsis, cohesiveness.

Treatment matching: evidence-based practice integrates best research evidence, clinical expertise, and patient values/preferences.

SSRIs first-line for depression/anxiety: block serotonin reuptake; onset 2–4 weeks; risks include GI upset, sexual dysfunction, hyponatremia in elderly, serotonin syndrome.

Serotonin syndrome triad: mental status change, autonomic instability, neuromuscular hyperactivity (clonus, hyperreflexia); stop serotonergic agents.

Benzodiazepines enhance GABA-A; risks: sedation, tolerance, dependence, respiratory depression with opioids; avoid in substance use disorders.

Antipsychotics: D2 blockade; typical (haloperidol) high EPS risk; atypical (risperidone, olanzapine, clozapine) metabolic risk; clozapine requires WBC monitoring for agranulocytosis.

Mood stabilizers: lithium (monitor levels 0.6–1.2 mEq/L, thyroid, renal), valproate (hepatotoxicity, teratogenic), lamotrigine (Stevens-Johnson risk with rapid titration).

Antidepressant classes: SSRIs, SNRIs, TCAs (anticholinergic, cardiac conduction risk), MAOIs (tyramine interaction, hypertensive crisis).

Dopamine pathways: mesolimbic (reward/psychosis), mesocortical (negative symptoms), nigrostriatal (EPS), tuberoinfundibular (prolactin).

Neurotransmitter basics: serotonin (mood, sleep, appetite), norepinephrine (arousal), dopamine (reward, motor), GABA (inhibitory), glutamate (excitatory).

Pharmacokinetics: absorption, distribution, metabolism (CYP450), excretion; half-life determines dosing interval and washout.

Piaget stages: sensorimotor (0–2), preoperational (2–7), concrete operational (7–11), formal operational (11+); object permanence emerges in sensorimotor.

Erikson psychosocial stages: trust/mistrust, autonomy/shame, initiative/guilt, industry/inferiority, identity/role confusion, intimacy, generativity, integrity.

Attachment (Ainsworth): secure, anxious-ambivalent, avoidant, disorganized; Strange Situation assesses infants 12–18 months.

Language milestones: babbling ~6 months, first words ~12 months, two-word phrases ~24 months, sentences by 3 years.

Autism spectrum: deficits in social communication plus restricted/repetitive behaviors, onset early developmental period; screen with M-CHAT.

ADHD: inattention and/or hyperactivity-impulsivity, ≥6 months, present before age 12, across ≥2 settings.

Dementia vs delirium: delirium acute, fluctuating attention, reversible; dementia progressive, stable consciousness, memory decline.

Normal aging: fluid intelligence declines, crystallized intelligence preserved; processing speed and working memory decline.

Adolescent development: identity formation, peer influence peaks, risk-taking linked to immature prefrontal control relative to limbic reward systems.

Cultural formulation: assess cultural identity, explanations of illness, stressors/supports, clinician-patient relationship, and cultural factors in diagnosis.

Collectivist versus individualist orientation influences symptom expression, family involvement, and help-seeking; Kuwaiti society emphasizes family and religious frameworks.

Stigma and family honor can delay help-seeking; confidentiality concerns are heightened in close-knit communities.

Family systems concepts: boundaries, triangulation, homeostasis, differentiation, multigenerational patterns.

Minuchin structural family therapy: enmeshment vs disengagement, hierarchy, subsystems; restructure boundaries.

Bowen: differentiation of self, anxiety, triangles, emotional cutoff; genogram maps multigenerational patterns.

Social psychology: fundamental attribution error, conformity (Asch), obedience (Milgram), bystander effect, cognitive dissonance.

Acculturation strategies (Berry): integration, assimilation, separation, marginalization; integration generally associated with better adjustment.

Religious and spiritual coping is common in the Gulf; assess beliefs without pathologizing normative practice.

Study designs: RCT (causal inference), cohort (incidence/risk), case-control (odds ratio), cross-sectional (prevalence, no temporality), case series (hypothesis-generating).

Validity threats: internal (confounding, attrition, maturation), external (generalizability), construct, statistical conclusion.

p-value = probability of data given null; α = 0.05 means 5% false-positive rate; p is not the probability the null is true.

Type I error = rejecting true null (α); Type II error = failing to reject false null (β); power = 1 − β, conventionally ≥0.80.

Effect sizes: Cohen's d (0.2 small, 0.5 medium, 0.8 large); r (0.1, 0.3, 0.5); odds ratio >1 indicates increased odds.

t-test compares means (independent/paired); ANOVA for ≥3 groups; chi-square for categorical association; correlation does not establish causation.

Regression predicts outcome from predictors; beta weights indicate unique contribution; multicollinearity inflates standard errors.

Systematic review/meta-analysis pools effect sizes with heterogeneity (I²); forest plots display study estimates and pooled effect.

EBP levels: systematic reviews/RCTs above cohort/case-control above case reports/expert opinion; appraise risk of bias.

Informed consent requires capacity, disclosure of risks/benefits/alternatives, voluntariness, and documentation.

Confidentiality limits: risk of serious harm to self or others, child/elder abuse, court order, and valid written authorization.

Duty to protect/warn: when a client poses serious threat to an identifiable person, take protective action per law and document reasoning.

Multiple relationships should be avoided when they could impair objectivity or exploit; document any unavoidable dual role.

Boundaries of competence: practice within training and supervised experience; seek consultation or refer when outside competence.

Record-keeping: maintain accurate, timely, secure records; retention per institutional and Kuwait MOH requirements; release only with consent or legal mandate.

Research ethics: IRB approval, informed consent, confidentiality, minimal risk, right to withdraw, no coercion.

Assessment ethics: use instruments with appropriate validity for population; disclose limits of interpretation; avoid misusing tests.

Patient safety: assess suicide/violence risk, medication side effects, and environmental hazards; report adverse events per policy.

Suicide risk assessment domains: ideation, plan, intent, means access, prior attempts, protective factors, substance use, hopelessness.

High acute risk indicators: specific plan, lethal means, intent, recent loss, agitation, command hallucinations, access to firearms.

Safety planning: recognize warning signs, coping strategies, social contacts, means restriction, crisis lines, emergency steps.

Columbia Suicide Severity Rating Scale (C-SSRS) grades ideation 1–5 and behavior; document level and timeframe.

Crisis intervention phases: establish rapport, assess safety, contain emotions, explore options, formulate plan, follow up.

De-escalation: calm tone, reduce stimulation, respect space, offer choices, avoid arguing with delusions; use physical intervention only as last resort per policy.

Acute stress and grief: normalize reactions, provide psychological first aid (safety, stabilization, connection, information), avoid mandatory debriefing.

Postvention after suicide: support bereaved, address contagion risk, coordinate with family and community.

Documentation: record risk level, rationale, actions taken, consultation, and follow-up plan with timestamps.

Licensure: psychologists practice under Kuwait MOH/Ministry of Health registration and licensing; scope defined by qualification and license category.

Practice settings: government hospitals, primary care, Kuwait Centre for Mental Health, and licensed private clinics; referrals follow MOH pathways.

Documentation standards: maintain clinical records in Arabic or English per facility policy; record consent, assessment, diagnosis, treatment plan, and progress.

Confidentiality is governed by professional ethics and Kuwaiti law; disclosure requires consent or legal/regulatory mandate.

Involuntary assessment/admission follows legal provisions for mental health protection; document capacity and justification.

Infection control, patient identification, and incident reporting follow MOH patient-safety directives.

Continuing professional development and supervision are expected for license renewal and quality assurance.

Cultural competence: provide services respectful of Kuwaiti cultural and religious values; use interpreters when needed and document.

Verify current circulars and facility policies; regulations change and supersede prior guidance.